+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antimicrobial and anti-inflammatory effects of clarithromycin on Mycobacterium avium complex replication in cultured human bronchial epithelial cells

Antimicrobial and anti-inflammatory effects of clarithromycin on Mycobacterium avium complex replication in cultured human bronchial epithelial cells

Journal of Infection and ChemoTherapy 18(5): 683-688

The Mycobacterium avium complex (MAC) invades cultured human bronchial cells, can replicate intracellularly, and facilitates the release of inflammatory cytokines and chemokines from cells. The purpose of this study was to examine the effects of clarithromycin (CAM) on MAC invasion, replication, and the release of cytokines and chemokines. A human bronchial epithelial cell line (BEAS-2B) monolayer grown on a tissue culture plate was infected with MAC. After 24 h, the cells were washed with Hanks' buffered salt solution, and extracellular bacteria were killed. The monolayer was further cultured for 5 days in medium containing CAM and subjected to a replication assay. The supernatants were assessed using a microchemotaxis assay and enzyme-linked immunosorbent assay (ELISA). mRNA expression was evaluated using a DNA array. The amount of intracellular MAC on day 5 of culture was significantly lower in the presence of CAM at the levels of 1× and 4× MIC. CAM inhibited the release of chemotactic activity and the production of interleukin (IL)-8 and macrophage chemotactic protein (MCP)-1. DNA array analysis of mRNA expression in BEAS-2B cells showed that CAM inhibited the expression of inflammatory cytokines and chemokines, involving IL-6, MCP-1, and IL-8 mRNA. MAC invaded and replicated in BEAS-2B cells and induced the production of chemotactic factors. In contrast, CAM may have bactericidal and bacteriostatic effects leading to the inhibition of inflammatory events.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036350517

Download citation: RISBibTeXText

PMID: 22370922

DOI: 10.1007/s10156-012-0395-6

Related references

Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells. Journal of Antimicrobial ChemoTherapy 43(3): 351-357, 1999

Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. International Journal of Antimicrobial Agents 16(1): 25-29, 2000

Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. Antimicrobial Agents and ChemoTherapy 36(10): 2104-2107, 1992

Analysis of inflammatory substances associated with intracellular amplification of Mycobacterium avium BEAS-2B cells and suppressive effects of clarithromycin. Japanese Journal of Antibiotics 62 Suppl A: 44-47, 2009

MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines. Kekkaku 74(7): 571-577, 1999

Anti-inflammatory effects of triptolide in human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 279(5): L958-L966, 2000

Anti-inflammatory effects of antibacterials on human Bronchial epithelial cells. Respiratory Research 10: 89, 2009

Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. Antimicrobial Agents and ChemoTherapy 38(12): 2738-2742, 1994

Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex. International Journal of Antimicrobial Agents 19(2): 139-145, 2002

Antimicrobial activities of rifalazil, levofloxacin, and clarithromycin against Mycobacterium tuberculosis and M avium complex replicating in 7HSF medium or in macrophages. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 156, 2002

Clarithromycin decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma: effects on IL-6, IL-8 and IL-33. Archives of Pharmacal Research 2017:, 2017

Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. Journal of Antimicrobial ChemoTherapy 41(1): 77-83, 1998

In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients. Journal of ChemoTherapy 3(6): 357-362, 1991

Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease. Pulmonary Pharmacology and Therapeutics 22(3): 190-193, 2009

Interaction of Mycobacterium avium complex with human respiratory epithelial cells. Journal of Infectious Diseases 181(3): 1189-1193, 2000